Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Serotonin transporter polymorphism (5-HTTLPR) and citalopram effectiveness and side effects in children with depression and/or anxiety disorders.

Journal of child and adolescent psychopharmacology - 1 Dec 2007

Kronenberg Sefi, Apter Alan, Brent David, Schirman Shella, Melhem Nadine, Pick Nimrod, Gothelf Doron, Carmel Miri, Frisch Amos, Weizman Abraham

Abstract excerpt

OBJECTIVE: The aim of this study was to examine the association between polymorphism in the serotonin transporter gene and citalopram effectiveness and side effects in children and adolescents with major depressive disorder (MDD) and/or anxiety disorders. METHODS: Outpatients, aged 7- 18 years wi...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antidepressive Agents, Second-Generation
Share to Anxiety Disorders

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Citalopram

Share to Depressive Disorder, Major

Share to Psychometrics

Share to Serotonin Plasma Membrane Transport Proteins

Share to Severity of Illness Index

Share to Suicide

Source

Identifiers

PMID: 18315446
DOI: 10.1089/cap.2006.0144

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-18315446-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Serotonin transporter polymorphism (5-HTTLPR) and citalopram effectiveness and side effects in children with depression and/or anxiety disorders.PMID 18315446Read ↗

Association between a functional serotonin transporter promoter polymorphism and citalopram treatment in adult outpatients with major depression.Semantic proximity Read ↗

Effects of serotonin transporter promoter polymorphisms on serotonin function.Semantic proximity Read ↗

Antidepressant response and the serotonin transporter gene-linked polymorphic region.Semantic proximity Read ↗

Pharmacogenetics of citalopram-related side effects in children with depression and/or anxiety disordersSemantic proximity Read ↗

5-HTTLPR modulates antidepressant efficacy in depressed women.Semantic proximity Read ↗

Serotonin transporter (5-HTT) promoter genotype may influence the prolactin response to clomipramine.Semantic proximity Read ↗

Additive effects of 5-HTTLPR (serotonin transporter) and tryptophan hydroxylase 2 G-703T gene polymorphisms on the clinical response to citalopram among children and adolescents with depression and anxiety disorders.Semantic proximity Read ↗

Effects of the serotonin transporter gene promoter polymorphism on mirtazapine and paroxetine efficacy and adverse events in geriatric major depression.Semantic proximity Read ↗

Polymorphisms of serotonin neurotransmission and their effects on antipsychotic drug action.Semantic proximity Read ↗

The serotonin transporter polymorphism, 5HTTLPR, is associated with a faster response time to sertraline in an elderly population with major depressive disorder.Semantic proximity Read ↗

Serotonin transporter 5-HTTLPR polymorphism and escitalopram treatment response in patients with major depressive disorder.Semantic proximity Read ↗

Serotonin Transporter Gene Polymorphisms and Selective Serotonin Reuptake Inhibitor Tolerability: Review of Pharmacogenetic EvidenceSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.